Skip to main content

Table 1 Demographic and clinical features of PM/DM patients and healthy controls

From: Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis

 

PM/DM patients

Healthy controls

Age of onset, mean ± SD (range) years

50.6 ± 17.4 (21.5 to 75.0)

51.4 ±9.4 (27 to 70)

Number of females/number of males

77/21

27/10

Number of PM patients/number of DM patients

41/57

NA

Duration of disease, mean ± SD (range) years

5.3 ± 7.6 (1.3 to 28.0)

NA

Clinical features, number of patients affected (% of cohort)

  

  Interstitial lung disease

50 (51.0%)

NA

  Oropharyngeal dysphagia

35 (35.7%)

NA

  Raynaud’s phenomenon

20 (20.4%)

NA

  Mechanic’s hands

12 (12.2%)

NA

  Arthritis

45 (45.9%)

NA

Anti-Jo-1-positive at time of blood sampling

20 (20.4%)

NA

Levels of creatine kinase at initial visit, mean ± SD

1437.2 ± 1536.5

NA

  1. PM, polymyositis; DM, dermatomyositis; NA, not applicable.